Stoke Therapeutics, Inc.
| CIK |
Ticker |
Name |
Accession Number |
Date |
Form |
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-25-089188 |
2025-04-22 16:05:27 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-24-106979 |
2024-04-23 16:06:27 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-23-245609 |
2023-09-28 16:05:26 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-23-236901 |
2023-09-18 16:05:27 |
PRE 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-23-122085 |
2023-04-27 16:01:51 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-23-103615 |
2023-04-17 16:01:59 |
PRE 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-22-120199 |
2022-04-26 16:02:01 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-21-131444 |
2021-04-26 16:02:01 |
DEF 14A
|
| 1623526 |
|
Stoke Therapeutics, Inc. |
0001193125-20-113542 |
2020-04-21 16:16:04 |
DEF 14A
|
